cbdMD annual debt-to-equity ratio
2019
2020
2021
2022
2023
2024
2025
cbdMD Debt-to-Equity Ratio Growth & History (YCBD)
cbdMD's debt-to-equity ratio was 0.11 for fiscal 2025.
View full cbdMD company overviewcbdMD annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | 0.11 | 0.06 | +114.25% |
| 2024 | 2024-09-30 | 0.05 | −0.39 | −88.54% |
| 2023 | 2023-09-30 | 0.44 | 0.31 | +237.27% |
| 2022 | 2022-09-30 | 0.13 | 0.07 | +119.19% |
| 2021 | 2021-09-30 | 0.06 | −0.03 | −36.81% |
| 2020 | 2020-09-30 | 0.09 | 0.09 | — |
| 2019 | 2019-09-30 | 0.00 | — | — |
cbdMD quarterly debt-to-equity ratio
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | 0.27 | 0.11 | +69.16% |
| Q2 2026 | 2026-03-31 | 0.04 | −1.68 | −97.45% |
| Q1 2026 | 2025-12-31 | 0.07 | −0.64 | −90.78% |
| Q4 2025 | 2025-09-30 | 0.11 | 0.06 | +114.25% |
| Q3 2025 | 2025-06-30 | 0.16 | −0.73 | −82.31% |
| Q2 2025 | 2025-03-31 | 1.72 | 0.73 | +73.98% |
| Q1 2025 | 2024-12-31 | 0.71 | 0.23 | +48.12% |
| Q4 2024 | 2024-09-30 | 0.05 | −0.39 | −88.54% |
| Q3 2024 | 2024-06-30 | 0.89 | 0.74 | +475.18% |
| Q2 2024 | 2024-03-31 | 0.99 | 0.82 | +495.76% |
| Q1 2024 | 2023-12-31 | 0.48 | 0.31 | +178.46% |
| Q4 2023 | 2023-09-30 | 0.44 | 0.31 | +237.27% |
| Q3 2023 | 2023-06-30 | 0.15 | 0.04 | +37.00% |
| Q2 2023 | 2023-03-31 | 0.17 | 0.10 | +141.76% |
| Q1 2023 | 2022-12-31 | 0.17 | 0.10 | +150.94% |
| Q4 2022 | 2022-09-30 | 0.13 | 0.07 | +119.19% |
| Q3 2022 | 2022-06-30 | 0.11 | 0.04 | +56.49% |
| Q2 2022 | 2022-03-31 | 0.07 | −0.01 | −11.07% |
| Q1 2022 | 2021-12-31 | 0.07 | −0.01 | −15.27% |
| Q4 2021 | 2021-09-30 | 0.06 | −0.03 | −36.81% |
| Q3 2021 | 2021-06-30 | 0.07 | −0.02 | −18.61% |
| Q2 2021 | 2021-03-31 | 0.08 | −0.01 | −7.44% |
| Q1 2021 | 2020-12-31 | 0.08 | −0.06 | −43.53% |
| Q4 2020 | 2020-09-30 | 0.09 | 0.09 | — |
| Q3 2020 | 2020-06-30 | 0.09 | — | — |
| Q2 2020 | 2020-03-31 | 0.08 | — | — |
| Q1 2020 | 2019-12-31 | 0.14 | — | — |
| Q4 2019 | 2019-09-30 | 0.00 | — | — |
cbdMD debt-to-equity ratio trends
Over the last five fiscal years, cbdMD's debt-to-equity ratio increased from 0.09 to 0.11, a change of 0.01. The latest reported quarter, Q3 2026, shows 0.27.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review cbdMD source filings ↗